Cargando…
Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312*)
Metabolic associated fatty liver disease became the most common form of chronic liver disease, in the vast majority of the cases related to increased insulin resistance or metabolic dysregulation. Yet, other causes may be implied. We report the late diagnosis of Dorfman-Chanarin syndrome in a non-al...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274987/ https://www.ncbi.nlm.nih.gov/pubmed/35979251 http://dx.doi.org/10.1159/000517103 |
_version_ | 1784745401544343552 |
---|---|
author | Quelhas da Costa, Rita Laranjeira, Francisco Duarte Ribeiro, Isaura Santos, António Filipe Nery, Filipe |
author_facet | Quelhas da Costa, Rita Laranjeira, Francisco Duarte Ribeiro, Isaura Santos, António Filipe Nery, Filipe |
author_sort | Quelhas da Costa, Rita |
collection | PubMed |
description | Metabolic associated fatty liver disease became the most common form of chronic liver disease, in the vast majority of the cases related to increased insulin resistance or metabolic dysregulation. Yet, other causes may be implied. We report the late diagnosis of Dorfman-Chanarin syndrome in a non-alcoholic steatohepatitis previously labeled cirrhotic middle-aged man, with consanguineous parents, complicated with hepatocellular carcinoma. Congenital ichthyosis, neurosensory hearing loss and elevated muscular enzymes hit on the track of Dorfman-Chanarin syndrome. The genetic analysis uncovered a first-time described homozygotic nonsense mutation in the ABHD5 gene, responsible for coding the ABHD5 protein. The patient was successfully submitted to liver transplantation. Inborn errors of metabolism are a rare cause of metabolic associated fatty liver disease, but they need to be kept in consideration in all patients who present with atypical clinical features. This shall raise the awareness of physicians to rare forms of presentation since it may imply not only a different prognosis, but also other actions, like particular therapies as liver transplantation due to related complications of cirrhosis, or familial screening. |
format | Online Article Text |
id | pubmed-9274987 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-92749872022-08-16 Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312*) Quelhas da Costa, Rita Laranjeira, Francisco Duarte Ribeiro, Isaura Santos, António Filipe Nery, Filipe GE Port J Gastroenterol Clinical Case Study Metabolic associated fatty liver disease became the most common form of chronic liver disease, in the vast majority of the cases related to increased insulin resistance or metabolic dysregulation. Yet, other causes may be implied. We report the late diagnosis of Dorfman-Chanarin syndrome in a non-alcoholic steatohepatitis previously labeled cirrhotic middle-aged man, with consanguineous parents, complicated with hepatocellular carcinoma. Congenital ichthyosis, neurosensory hearing loss and elevated muscular enzymes hit on the track of Dorfman-Chanarin syndrome. The genetic analysis uncovered a first-time described homozygotic nonsense mutation in the ABHD5 gene, responsible for coding the ABHD5 protein. The patient was successfully submitted to liver transplantation. Inborn errors of metabolism are a rare cause of metabolic associated fatty liver disease, but they need to be kept in consideration in all patients who present with atypical clinical features. This shall raise the awareness of physicians to rare forms of presentation since it may imply not only a different prognosis, but also other actions, like particular therapies as liver transplantation due to related complications of cirrhosis, or familial screening. S. Karger AG 2021-07-07 /pmc/articles/PMC9274987/ /pubmed/35979251 http://dx.doi.org/10.1159/000517103 Text en Copyright © 2021 by Sociedade Portuguesa de Gastrenterologia Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. |
spellingShingle | Clinical Case Study Quelhas da Costa, Rita Laranjeira, Francisco Duarte Ribeiro, Isaura Santos, António Filipe Nery, Filipe Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312*) |
title | Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312*) |
title_full | Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312*) |
title_fullStr | Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312*) |
title_full_unstemmed | Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312*) |
title_short | Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312*) |
title_sort | dorfman-chanarin syndrome: a rare cause of metabolic associated fatty liver disease related to homozygosity of the nonsense mutation c.934c>t (p.r312*) |
topic | Clinical Case Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274987/ https://www.ncbi.nlm.nih.gov/pubmed/35979251 http://dx.doi.org/10.1159/000517103 |
work_keys_str_mv | AT quelhasdacostarita dorfmanchanarinsyndromeararecauseofmetabolicassociatedfattyliverdiseaserelatedtohomozygosityofthenonsensemutationc934ctpr312 AT laranjeirafrancisco dorfmanchanarinsyndromeararecauseofmetabolicassociatedfattyliverdiseaserelatedtohomozygosityofthenonsensemutationc934ctpr312 AT duarteribeiroisaura dorfmanchanarinsyndromeararecauseofmetabolicassociatedfattyliverdiseaserelatedtohomozygosityofthenonsensemutationc934ctpr312 AT santosantoniofilipe dorfmanchanarinsyndromeararecauseofmetabolicassociatedfattyliverdiseaserelatedtohomozygosityofthenonsensemutationc934ctpr312 AT neryfilipe dorfmanchanarinsyndromeararecauseofmetabolicassociatedfattyliverdiseaserelatedtohomozygosityofthenonsensemutationc934ctpr312 |